Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence

Pancreatic Cancer

Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609

Pancreatic cancer

Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471

Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497

Senescence in premalignant tumours

Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482

Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice

Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224

Senescence in tumours: evidence from mice and humans

Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 4×

Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis

Thomas, M. M., Zhang, Y.-Q., Mathew, E., Kane, K. T., Maillard, I., & di Magliano, M. P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-862 · Cited by 36

Cells of origin of pancreatic neoplasms

Yamaguchi, J., Yokoyama, Y., Kokuryo, T., Ebata, T., & Nagino, M. (2017) · Surgery Today · doi:10.1007/s00595-017-1501-2 · Cited by 40

Vaccines for Pancreatic Cancer

Soares, K. C., Zheng, L., Edil, B. H., & Jaffee, E. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182756903 · Cited by 38

Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma

Schofield, H. K., Zeller, J., Espinoza, C. E., Halbrook, C. J., Vecchio, A. D., Magnuson, B., Fabo, T., Daylan, A. E. C., Kovalenko, I., Lee, H., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97422 · Cited by 38

Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer

Calcinotto, A., & Alimonti, A. (2017) · Swiss Medical Weekly · doi:10.57187/smw.2017.14367 · Cited by 42

κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis

Beel, S., Kolloch, L. J., Apken, L. H., Jürgens, L., Bolle, A., Sudhof, N., Ghosh, S., Wardelmann, E., Meisterernst, M., Steinestel, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17226-0 · Cited by 37

Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic TargetsPreprint

Drosten, M., Guerra, C. E., & Barbacid, M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031542 · Cited by 43

Roles of differently polarized macrophages in the initiation and progressionof pancreatic cancer

Störz, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237711 · Cited by 36

Plasticity of differentiated cells in wound repair and tumorigenesis, part I: stomach and pancreas

Burclaff, J., & Mills, J. C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033373 · Cited by 36

Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells

Parajuli, P., Nguyen, T. L., Prunier, C., Razzaque, M. S., Xu, K., & Atfi, A. (2020) · Life Science Alliance · doi:10.26508/lsa.201900573 · Cited by 36

Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A

Zhao, Y., Wu, Z., Chanal, M., Guillaumond, F., Goehrig, D., Bachy, S., Principe, M., Ziverec, A., Flaman, J., Collin, G., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3763 · Cited by 38

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance

Malinova, A., Veghini, L., Real, F. X., & Corbo, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795251 · Cited by 39

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors

Hindriksen, S., & Bijlsma, M. F. (2012) · Cancers · doi:10.3390/cancers4040989 · Cited by 35

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis

Ikezawa, K., Hikita, H., Shigekawa, M., Iwahashi, K., Eguchi, H., Sakamori, R., Tatsumi, T., & Takehara, T. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.02.001 · Cited by 35

Animal Models

Saloman, J. L., Albers, K. M., Cruz‐Monserrate, Z., Davis, B. M., Edderkaoui, M., Eibl, G., Epouhe, A. Y., Gedeon, J. Y., Gorelick, F. S., Grippo, P. J., et al. (2019) · Pancreas · doi:10.1097/mpa.0000000000001335 · Cited by 35

Critical role of oncogenic KRAS in pancreatic cancer (Review)

Liu, J., Ji, S., Liang, C., Qin, Y., Jin, K., Liang, D., Xu, W., Shi, S., Zhang, B., Liu, L., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5196 · Cited by 36

Titration of RAS alters senescent state and influences tumour initiation

Chan, A. S. L., Zhu, H., Narita, M., Cassidy, L. D., Young, A. R. J., Bermejo‐Rodríguez, C., Janowska, A. T., Chen, H., Gough, S., Oshimori, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07797-z · Cited by 38

Tumour suppressor gene function in carcinoma‐associated fibroblasts: from tumour cells via EMT and back again?

Drake, L. E., & Macleod, K. F. (2013) · The Journal of Pathology · doi:10.1002/path.4298 · Cited by 34

Disruptive chemicals, senescence and immortality

Carnero, A., Blanco‐Aparicio, C., Kondoh, H., LLeonart, M. E., Martínez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 36

Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas

Maier, H. J., Wagner, M., Schips, T. G., Salem, H. H., Baumann, B., & Wirth, T. C. (2012) · Oncogene · doi:10.1038/onc.2012.272 · Cited by 34

Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation

Grasso, D., Bintz, J., Lomberk, G. A., Molejon, M. I., Loncle, C., Garcia, M. N., López‐Millán, B., Urrutia, R. A., & Iovanna, J. (2015) · Scientific Reports · doi:10.1038/srep17549 · Cited by 37

Metabolomics bridging proteomics along metabolites/oncometabolites and protein modifications: Paving the way toward integrative multiomics

Nalbantoğlu, S., & Karadağ, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114031 · Cited by 34

Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism

Bednar, F., Schofield, H. K., Collins, M. A., Yan, W., Zhang, Y., Shyam, N., Eberle-Singh, J. A., Almada, L. L., Olive, K. P., Bardeesy, N. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv058 · Cited by 35

Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer

Metzger, P., Kirchleitner, S. V., Kluge, M., König, L. M., Hörth, C., Rambuscheck, C. A., Böhmer, D., Ahlfeld, J., Kobold, S., Friedel, C. C., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0778-7 · Cited by 33

Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis

Nishikawa, Y., Kodama, Y., Shiokawa, M., Matsumori, T., Marui, S., Kuriyama, K., Kuwada, T., Sogabe, Y., Kakiuchi, N., Tomono, T., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0718-5 · Cited by 32

Impaired JNK Signaling Cooperates with KrasG12D Expression to Accelerate Pancreatic Ductal Adenocarcinoma

Davies, C. C., Harvey, E., McMahon, R. F., Finegan, K. G., Connor, F., Davis, R. J., Tuveson, D. A., & Tournier, C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2941 · Cited by 32

Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis

Karki, A., Humphrey, S. E., Steele, R. E., Hess, D. A., Taparowsky, E. J., & Konieczny, S. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145724 · Cited by 32

Inflammation to cancer: The molecular biology in the pancreas (Review)

Ling, S., Feng, T., Jia, K., Tian, Y., & LI, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.2003 · Cited by 32

Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia

Narlik‐Grassow, M., Blanco‐Aparicio, C., Cecilia, Y., Pérez, M., Muñoz-Galván, S., Cañamero, M., & Carnero, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060277 · Cited by 29

Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation

Youssef, I., & Ricort, J. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0125 · Cited by 31

Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction

Kanda, Y., Osaki, M., & Okada, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040867 · Cited by 32

The cholesterol‐binding protein NPC2 restrains recruitment of stromal macrophage‐lineage cells to early‐stage lung tumours

Kamata, T., Jin, H., Giblett, S. M., PATEL, B., Patel, F., Foster, C., & Pritchard, C. A. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404838 · Cited by 29

Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis

Matsuura, T., Maru, Y., Izumiya, M., Hoshi, D., Kato, S., Ochiai, M., Hori, M., Yamamoto, S., Tatsuno, K., Imai, T., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz122 · Cited by 30

The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer

Qian, W., Chen, K., Qin, T., Xiao, Y., Li, J., Yue, Y., Zhou, C., Ma, J., Duan, W., Lei, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01823-4 · Cited by 30

Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy

Liu, L., Han, S., Xiao, X., An, X., Gladkich, J., Hinz, U., Hillmer, S., Hoppe‐Tichy, T., Xu, Y., Schaefer, M., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05503-3 · Cited by 30

Human Correlates of Provocative Questions in Pancreatic Pathology

McDonald, O. G., Maitra, A., & Hruban, R. H. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e318273f998 · Cited by 30

Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer

Delgado, O., Batten, K. G., Richardson, J. A., Xie, X.-J., Gazdar, A. F., Kaisani, A. A., Girard, L., Behrens, C., Suraokar, M. B., Fasciani, G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2589 · Cited by 30

Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis

Jiang, Z., Wu, F., Laise, P., Tanaka, T., Fu, N., Kim, W., Kobayashi, H., Chang, W., Takahashi, R., Valenti, G., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.07.002 · Cited by 29

Inflammatory macrophages in pancreatic acinar cell metaplasia and initiation of pancreatic cancer

Liou, G., & Störz, P. (2015) · Oncoscience · doi:10.18632/oncoscience.151 · Cited by 29

Eicosanoid regulation of debris-stimulated metastasis

Deng, J., Yang, H., Haak, V. M., Yang, J., Kipper, F. C., Barksdale, C., Hwang, S. H., Gartung, A., Bielenberg, D. R., Subbian, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107771118 · Cited by 29

YTHDF2 Regulates Macrophage Polarization through NF-κB and MAPK Signaling Pathway Inhibition or p53 Degradation

Cai, L., Li, D., Feng, Z., Gu, X., Xu, Q., & Li, Q. (2022) · Disease Markers · doi:10.1155/2022/3153362 · Cited by 29

Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches

van Miltenburg, M. H., & Jonkers, J. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.01.004 · Cited by 32

Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas

Coppola, D., Balducci, L., Chen, D., Loboda, A. P., Nebozhyn, M., Staller, A., Fulp, W. J., Dalton, W. S., Yeatman, T. J., & Brem, S. S. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.08.003 · Cited by 29

Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates

Deschênes‐Simard, X., Malleshaiah, M. K., & Ferbeyre, G. (2023) · Cancers · doi:10.3390/cancers16010095 · Cited by 27

Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer

Kujundžić, R. N., Prpić, M., Đaković, N., Dabelić, N., Tomljanović, M., Mojzeš, A., Fröbe, A., & Gall‐Tros̆elj, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115681 · Cited by 28

Non-canonical functions of SNAIL drive context-specific cancer progression

Paul, M., Schneeweis, C., Falcomatà, C., Shan, C., Rossmeisl, D., Koutsouli, S., Klement, C., Żukowska, M., Widholz, S. A., Jesinghaus, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36505-0 · Cited by 27

The Tumor Suppressor rpl36 Restrains KRAS G12V -Induced Pancreatic Cancer

Provost, E., Bailey, J. M., Aldrugh, S., Liu, S., Iacobuzio–Donahue, C. A., & Leach, S. D. (2014) · Zebrafish · doi:10.1089/zeb.2014.1024 · Cited by 28

Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics

Singh, S. K., & Ellenrieder, V. (2013) · Gut · doi:10.1136/gutjnl-2012-302793 · Cited by 29

p21 WAF1 /Cip1 limits senescence and acinar‐to‐ductal metaplasia formation during pancreatitis

Grabliauskaite, K., Hehl, A. B., Seleznik, G. M., Saponara, E., Schlesinger, K., Zuellig, R. A., Dittmann, A., Bain, M., Reding, T., Sonda, S., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4440 · Cited by 27

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy

Gurreri, E., Genovese, G., Perelli, L., Agostini, A., Piro, G., Carbone, C., & Tortora, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119313 · Cited by 27

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

Unruh, D. J., Ünlü, B., Lewis, C. S., Qi, X., Chu, Z., Sturm, R., Keil, R. D., Ahmad, S. A., Sovershaev, T., Adam, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7955 · Cited by 27

Familial Pancreatic Ductal Adenocarcinoma.

Diaz, K., & Lucas, A. (2019) · American Journal of Pathology · doi:10.1016/j.ajpath.2018.06.026 · Cited by 24

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

Bansod, S., Dodhiawala, P. B., & Lim, K. (2021) · Cancers · doi:10.3390/cancers13215481 · Cited by 28

Dynamic Regulation of Expression of KRAS and Its Effectors Determines the Ability to Initiate Tumorigenesis in Pancreatic Acinar Cells

Assi, M., Achouri, Y., Loriot, A. E., Dauguet, N., Dahou, H., Baldan, J., Libert, M., Fain, J. S., Guerra, C. E., Bouwens, L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2976 · Cited by 27

Inflammation and Cancer

Kumar, S., Chan, C. J., & Coussens, L. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17002-x · Cited by 28

A historical perspective of pancreatic cancer mouse models

Colvin, E. K., & Scarlett, C. J. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.025 · Cited by 26

Characterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic Pancreatitis

Xu, S., Chheda, C., Ouhaddi, Y., Benhaddou, H., Bourhim, M., Grippo, P. J., Principe, D. R., Mascariñas, E., DeCant, B. T., Tsukamoto, H., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000380 · Cited by 25

Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer

Ma, X., Tao, R., Li, L., Chen, H., Liu, Z., Bai, J., Shuai, X., Wu, C., & Tao, K. (2018) · Oncology Reports · doi:10.3892/or.2018.6820 · Cited by 25

Characterization of genetic subclonal evolution in pancreatic cancer mouse models

Niknafs, N., Zhong, Y., Moral, J. A., Zhang, L., Shao, M. X., Lo, A., Makohon-Moore, A. P., Iacobuzio–Donahue, C. A., & Karchin, R. (2019) · Nature Communications · doi:10.1038/s41467-019-13100-w · Cited by 26

Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer

Gupta, S., Prajapati, A., Gulati, M., Gautam, S. K., Sushil Kumar, K., Dalal, V., Talmon, G. A., Rachagani, S., & Jain, M. (2020) · Neoplasia · doi:10.1016/j.neo.2019.11.001 · Cited by 25

Ductal metaplasia in pancreas

Li, S., & Xie, K. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188698 · Cited by 27

Arrested development and the great escape – The role of cellular senescence in pancreatic cancer

Moir, J. A. G., White, S. A., & Mann, J. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.018 · Cited by 26

The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth

Boone, B. A., Murthy, P., Miller-Ocuin, J. L., Liang, X., Russell, K. L., Loughran, P., Gawaz, M., Lotze, M. T., Zeh, H. J., & Vogel, S. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03692-0 · Cited by 25

The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in KrasG12D; Pdx1-Cre (KC) mice

Leal, A. S., Misek, S. A., Lisabeth, E. M., Neubig, R. R., & Liby, K. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43430-0 · Cited by 25

Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice

Johnson, B. L., Salazar, M. D., Mackenzie‐Dyck, S., D’Apuzzo, M., Shih, H.-P., Manuel, E. R., & Diamond, D. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221810 · Cited by 25

ACSS2 drives senescence-associated secretory phenotype by limiting purine biosynthesis through PAICS acetylation

Yang, L. C., You, J., Yang, X., Jiao, R., Xu, J., Zhang, Y., Mi, W., Zhu, L., Ye, Y., Ren, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57334-3 · Cited by 28

c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis

Lobo, V. J. S.-A., Fernández, L. C., Pau, E. C. D. S., Richart, L., Cobo, I., Cendrowski, J., Moreno‐Celis, U., del Pozo, N., Megı́as, D., Bréant, B., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312306 · Cited by 24

Prediagnostic Inflammation and Pancreatic Cancer Survival

Yuan, C., Morales‐Oyarvide, V., Khalaf, N. I., Perez, K. J., Tabung, F. K., Ho, G. Y. F., Kooperberg, C. L., Shadyab, A. H., Qi, L., Kraft, P. L., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab040 · Cited by 25

Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells

Wang, C., Hou, Y., Hong, Y., Tai, †. Y.-H., Shen, C., Hou, P., Fu, J.-L., Wu, C.-L., Cheng, S. M., Hwang, D., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02207-4 · Cited by 24

Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells

Simon, N. C., Antignani, A., Hewitt, S. M., Gadina, M., Alewine, C., & FitzGerald, D. J. (2019) · JCI Insight · doi:10.1172/jci.insight.123281 · Cited by 23

The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer

Leal, A. S., Liu, P., Krieger-Burke, T., Ruggeri, B., & Liby, K. T. (2020) · Cancers · doi:10.3390/cancers13010096 · Cited by 23

Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments

Conte, M., & Cauda, V. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200079 · Cited by 27

In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer

Martinez, S., Wu, S., Geuenich, M. J., Malik, A., Weber, R., Woo, T., Zhang, A. X. W., Jang, G. H., Dervovic, D., Al‐Zahrani, K. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49450-3 · Cited by 29

Targeting inflammation in pancreatic cancer: Clinical translation

Steele, C. W., Gill, N. A. K., Jamieson, N. B., & Carter, C. R. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i4.380 · Cited by 23

A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance

Spechler, S. J., Merchant, J. L., Wang, T. C., Chandrasoma, P. T., Fox, J. G., Genta, R. M., Goldenring, J. R., Hayakawa, Y., Kuipers, E. J., Lund, P. K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.050 · Cited by 23

Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models

DeCant, B. T., Principe, D. R., Guerra, C. E., di Magliano, M. P., & Grippo, P. J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00464 · Cited by 22

Increased Number of Non-Degranulated Mast Cells in Pancreatic Ductal Adenocarcinoma but Not in Acute Pancreatitis

Karamitopoulou, E., Shoni, M., & Theoharides, T. C. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700208 · Cited by 22

Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS

Wang, D., Bi, Y., Hu, L., Luo, Y., Ji, J., Mao, A. H., Logsdon, C. D., Li, E., Abbruzzese, J. L., Li, Z., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0333-7 · Cited by 22

Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer

Zhang, W., Zhang, K., Zhang, P., Zheng, J., Min, C., & Li, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604531 · Cited by 22

A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3

Lahtela, J., Corson, L. B., Hemmes, A., Brauer, M. J., Koopal, S., Lee, J., Hunsaker, T. L., Jackson, P. K., & Verschuren, E. W. (2013) · Cell Cycle · doi:10.4161/cc.23515 · Cited by 20

Pancreatic STAT5 activation promotes Kras G12D -induced and inflammation-induced acinar-to-ductal metaplasia and pancreatic cancer

Lin, Y., Pu, S., Wang, J., Wan, Y., Wu, Z., Guo, Y., Feng, W., Ying, Y., Ma, S., Meng, X. J., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332225 · Cited by 21

Dynamic Aging: Channeled Through Microenvironment

Tan, Q., Liang, N., Zhang, X., & Li, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702276 · Cited by 25

TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma

Lundy, J., Gearing, L. J., Gao, H., West, A. C., McLeod, L., Deswaerte, V., Yu, L., Porazinski, S. R., Pajic, M., Hertzog, P. J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01992-2 · Cited by 21

The crosstalk between acinar cells withKrasmutations and M1-polarized macrophages leads to initiation of pancreatic precancerous lesions

Störz, P. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008794 · Cited by 21

HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells

Stone, S. C., Rossetti, R. A. M., Bolpetti, A. N., Boccardo, E., de Araujo‐Souza, P. S., & Lepique, A. P. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0513-282r · Cited by 21

Snail Cooperates with KrasG12D In Vivo to Increase Stem Cell Factor and Enhance Mast Cell Infiltration

Knab, L. M., Ebine, K., Chow, C. R., Raza, S. S., Sahai, V., Patel, A. P., Kumar, K., Bentrem, D. J., Grippo, P. J., & Munshi, H. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0111 · Cited by 20

CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma

Cannon, A. C., Thompson, C. M., Maurer, H. C., Atri, P., Bhatia, R., West, S. C., Ghersi, D., Olive, K. P., Sushil Kumar, K., & Batra, S. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1359 · Cited by 19

Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes

Schneeweis, C., Wirth, M., Saur, D., Reichert, M., & Schneider, G. (2016) · Small GTPases · doi:10.1080/21541248.2016.1262935 · Cited by 20

Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma

Fiorino, S., Lorenzini, S., Masetti, M., Deleonardi, G., Grondona, A. G., Silvestri, T., Chili, E., Prete, P. D., Reggiani, M. L. B., Cuppini, A., et al. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.008 · Cited by 19

Exposure to perfluorooctanoic acid leads to promotion of pancreatic cancer

Kamendulis, L. M., Hocevar, J. M., Stephens, M., Sandusky, G. E., & Hocevar, B. A. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac005 · Cited by 20

Context-Dependent Roles of Hes1 in the Adult Pancreas and Pancreatic Tumor Formation

Marui, S., Nishikawa, Y., Shiokawa, M., Yokode, M., Matsumoto, S., Muramoto, Y., Ota, S., Nakamura, T., Yoshida, H. K., Okada, H., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.08.048 · Cited by 19

Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma

Phillips, A. E., Shah, N., Borhani, A. A., Yadav, D. K., & Brand, R. E. (2018) · Pancreas · doi:10.1097/mpa.0000000000001160 · Cited by 19

A New Insight into Chronic Pancreatitis

Shimosegawa, T. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.248.225 · Cited by 19

Analysis of mRNA Profiles after MEK1/2 Inhibition in Human Pancreatic Cancer Cell Lines Reveals Pathways Involved in Drug Sensitivity

Gysin, S., Paquette, J., & McMahon, M. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0188 · Cited by 19

Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationship

Dibra, D., Mishra, L., & Li, S. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.001 · Cited by 19

PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response

Ye, J., Huang, A., Wang, H., Zhang, A. M. Y., Huang, X., Lan, Q., Sato, T., Goyama, S., Kurokawa, M., Deng, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2371-x · Cited by 19

Contrôle de la croissance et de la dissémination tumorales par le microenvironnement

Provot, S. (2014) · médecine/sciences · doi:10.1051/medsci/20143004008 · Cited by 19

MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway

Dutchak, K., Garnett, S., Nicoll, M., de Bruyns, A., & Dankort, D. L. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0767 · Cited by 18

Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies

Khan, S. U., Budamagunta, V., & Zhou, D. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.004 · Cited by 21

Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer

Rajbhandari, N., Hamilton, M., Quintero, C. M., Ferguson, L. P., Fox, R. G., Schürch, C. M., Wang, J., Nakamura, M., Lytle, N. K., McDermott, M. L., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.09.008 · Cited by 18

Highlights from Recent Cancer Literature

(2011) · Cancer Research · doi:10.1158/0008-5472.5363.71.16

Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras

Carrière, C., Young, A. L., Gunn, J. R., Longnecker, D. S., & Korc, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.068 · Cited by 236

Pancreatitis promotes oncogenic KrasG12D-induced pancreatic transformation through activation of Nupr1

Grasso, D., Garcia, M. N., Hamidi, T., Cano, C. E., Calvo, E. L., Lomberk, G. A., Urrutia, R. A., & Iovanna, J. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29913 · Cited by 4

Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice

Zhuang, L., Zhan, X., Bi, Y., & Ji, B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8879-2_25 · Cited by 5

Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras

Lineage, I. T. N. C. (2011)